Effect of (−)-epigallocatechin-3-gallate on human insulin fibrillation/aggregation kinetics

[Display omitted] ► A natural occurring polyphenol was found to inhibit the fibrillation of insulin. ► EGCG reduces the length and width of insulin fibrils at pH 2.0 and 60°C. ► EGCG redirects insulin into globular aggregates at pH 7.4 and 37°C. ► EGCG blocks the changes of the secondary structures...

Full description

Saved in:

Bibliographic Details
Published in:	Biochemical engineering journal 2012-04, Vol.63, p.38-49
Main Authors:	Wang, Shi-Hui, Dong, Xiao-Yan, Sun, Yan
Format:	Article
Language:	eng
Subjects:	(−)-Epigallocatechin-3-gallate Aggregation Biological and medical sciences Biophysical chemistry Biotechnology Fundamental and applied biological sciences. Psychology Inhibition Kinetic parameters Protein
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	[Display omitted] ► A natural occurring polyphenol was found to inhibit the fibrillation of insulin. ► EGCG reduces the length and width of insulin fibrils at pH 2.0 and 60°C. ► EGCG redirects insulin into globular aggregates at pH 7.4 and 37°C. ► EGCG blocks the changes of the secondary structures of insulin in the aggregation. ► EGCG suppresses the exposure of hydrophobic groups of insulin in the aggregation. (−)-Epigallocatechin-3-gallate (EGCG), a food additive derived from green tea, has been reported to effectively inhibit the fibrillation of many amyloid proteins, but not insulin. So herein, the influences of EGCG on the fibrillation kinetics of human insulin at two conditions (pH 2.0, 60°C and pH 7.4, 37°C) were extensively studied. It was found that at pH 2.0 and 60°C the inhibitory effect increased with increasing EGCG concentration from 0.35 to 3.5mmol/L but kept almost unchanged from 3.5 to 5mmol/L EGCG. The addition of EGCG reduced the length and width of fibrils and kept part of insulin from fibrillation at this condition. At pH 7.4 and 37°C, however, EGCG altered the fibrillation pathway of insulin and redirected it into globular aggregates, and the inhibitory effect of EGCG on the aggregation reached maximum at about 0.1–0.2mmol/L. In this case, part of insulin molecules were prevented from aggregation and existed as a mixture of monomer, dimer, tetramer, and hexamer in the solution. Circular dichroism spectroscopy indicated that EGCG slowed down the changes of the secondary structures of insulin in the aggregation. Finally, two physical models were proposed to explain the molecular interactions between insulin and EGCG at the two conditions. The research has clarified the kinetic mechanism of the inhibitory effect of EGCG on insulin fibrillation/aggregation.
ISSN:	1369-703X 1873-295X